http://www.balfourcapitalgroup.com/

Balfour Capital Group, G/F, 71 Lower Baggot Street, Dublin (2026)

09/06/2026

Markets are tanking. Non-farm payroll just dropped. It is 11:30 AM at the New York Stock Exchange - and Steve Alain Lawrence is live.

On June 5, 2026, Balfour Capital Group CIO Steve Alain Lawrence joined FEMACRO from the NYSE floor in real time as the NASDAQ sold off 2.4% on the back of the NFP release. What he said next is a masterclass in cutting through the noise.

Six calls. All on the record.
- Do not buy today - Dow targets 48,500–49,000 over the next 90 days. The retracement is coming and that decline is your entry - not today.
- Bitcoin is falling because of Middle East sovereign selling - UAE, Kuwait, Iran, Dubai need liquidity. They are not producing oil. They are selling Bitcoin and gold to raise cash. This is structural, not demand-driven.
- Dubai real estate is in free fall - large developers will take serious losses, new developments are on hold, and recovery will take three years minimum. Do not buy.
- Pharma is a buy across the board - Eli Lilly specifically called to make new highs. Merck, Novartis, Amylin, J&J, Amgen all named. The thesis is pipeline value.
- China will NOT invade Taiwan - the US and China are virtually connected and fuel the entire global economy. Taiwan risk is saber rattling. TSMC holders: stay positioned.
- Kevin Warsh's first Fed meeting will be even-keeled - he cannot cut rates. Inflation persists for at least one more year. No surprises.

In moments of maximum confusion, precision matters most.

Watch the full discussion: https://balfourcapitalgroup.com/media-coverage/

08/06/2026

🇨🇳 China's outbound investment curbs take effect July 1. Portfolios need compliance mapping now.

AsianInvestor (June 5) — China issued a sweeping State Council directive consolidating national security oversight of all overseas investments. Effective July 1, it bans cross-border transfers of restricted technology, data, services and personnel — with forced asset disposals and fines up to 1% of the investment amount.

Sectors facing the sharpest friction:
Semiconductors: cross-border tech directly in scope
- AI: IP walks out with the people — a structural constraint (Balfour Capital Group)
- Biotech: personnel deployment and training now prohibited
- Advanced manufacturing: dual-use technology transfers caught in scope
- Critical minerals and data platforms: subject to national security review with forced divestiture
- Joint ventures: no longer safe harbours

Balfour Capital Group's Hersh Oberoi — investor action plan:
- Immediate priority: compliance mapping on existing portfolios before July 1
- Strategic reorientation: reduce cross-border tech mandates; increase exposure to consumption, renewables and healthcare services in China
- The compliance burden is bilateral: firms between Beijing and Washington must build frameworks for two parallel enforcement regimes
- Outbound investment from China is now state-coordinated policy, not a purely commercial decision

Three institutional views:
- BNP Paribas AM (Zhikai Chen): constructive on ASEAN manufacturing relocation, China domestic tech upgrading and Hong Kong's financial hub role
- Arc Orient Pacific (Daniel Xystus): systematic reallocation required — back physical and digital infrastructure, not direct tech plays in the crossfire
- Kaiyuan Capital (Brock Silvers): short-term domestic tech upside — but welcoming inbound while restricting outbound won't convince Western investors China is back

https://balfourcapitalgroup.com/news/

08/06/2026

Balfour Capital Group has issued the following buy recommendations:

Beone Medicines Ag (NASDAQ: ONC) — June 8, 2026: Global oncology leader formerly BeiGene. HQ: San Carlos, CA. Trades NASDAQ/HKEX/Shanghai. Flagship: BRUKINSA® — best-in-class BTK inhibitor with proven CLL superiority and global revenue leadership. Also TEVIMBRA® + Amgen products. "Global superhighway" model: China, Europe, US. FY2026 revenue: $6.3–$6.5B. Market cap: $33.4B.

Nutrien Ltd (NYSE: NTR) — June 8, 2026: World's largest potash producer + leading nitrogen/phosphate. Born 2018 from PotashCorp + Agrium merger. HQ: Saskatoon, Canada. TSX/NYSE. 4 segments: Potash, Nitrogen, Phosphate + Retail (2,000+ locations, 3 continents). Q1 '26: record potash volumes, EBITDA $1.11B, EPS $0.51. Returned $409M to shareholders. Market cap: ~$33B USD.

CVR Partners LP (NYSE: UAN) — June 8, 2026: Nitrogen fertilizer MLP: ammonia + UAN from 2 plants (Kansas, Illinois). Majority-owned by CVR Energy (~36%). Sells wholesale to US corn/wheat growers. Variable distribution = payout flexes with earnings. Q1 '26: $4.00/unit. Annual: $12.28/unit. Yield: 10.2%. Market cap: $1.3B.

View all buy recommendations: https://balfourcapitalgroup.com/buy-recommendations/

04/06/2026

Balfour Capital Group has issued the following buy recommendations:

XPeng (NYSE: XPEV) — June 3, 2026: Chinese AI mobility company building smart EVs + humanoid robots + Robotaxi. NYSE: XPEV | HKEX: 9868. XNGP is China's top autonomous driving system. Four new 2026 models, GX just launched. Strong H2 volume recovery ahead.

Select Water Solutions Inc (NYSE: WTTR) — June 3, 2026: Sustainable water & chemicals for energy. Three segments: Water Infrastructure (highest-margin, fastest-growing), Chemical Technologies, Water Services. Long-term contracts with minimum volume commitments in Permian, Bakken, MidCon. Capital-efficient growth engine.

Us Bancorp (NYSE: USB) — June 3, 2026: $681B assets, $85B market cap. Fifth straight quarter of EPS growth + 440bps positive operating leverage. Consumer & commercial banking, payments, wealth management. Partners: Amazon (small biz credit), NFL (wealth). Disciplined multi-year strategy working.

View all buy recommendations: https://balfourcapitalgroup.com/buy-recommendations

02/06/2026

🇹🇼 Taiwan just overtook India as the world's fifth-largest equity market. One company explains most of the gap — and it's also the risk.

AsianInvestor gathered six institutional voices on the most significant reordering of Asia's equity landscape in years. Taiwan ($4.95T) has displaced India ($4.92T) — driven overwhelmingly by TSMC's 49% rally in 2026, which now comprises 42% of the TAIEX.

The structural data:
- TSMC: 42% of TAIEX, up 49% YTD — the physical infrastructure of the global AI buildout
- India: >$20B in YTD foreign outflows | oil vulnerability | rupee weakness | index anchored in banking, energy and consumer
- MSCI EM benchmark: Taiwan now #1 (overtook China in April) | Korea now #2 (overtook China last week)
- US hyperscaler AI spend: heading toward $1 trillion — landing disproportionately in Taiwan and Korea (WTW)

Balfour Capital's Hersh Oberoi — the two messages for allocators:
- Thematic signal: markets with direct, scaled exposure to AI semiconductor - manufacturing are commanding a structural premium
- Risk management warning: TAIEX has become a leveraged single-stock bet on AI capex and cross-strait stability
- Tail risk underpriced: prediction markets imply 22% probability of conflict by 2027 — volatility premia historically subdued relative to that risk

Three additional institutional views:
- Allspring's Gary Tan: barbell approach — AI beneficiaries in North Asia + domestic demand in India. Diversification is key as the AI cycle matures.
- WTW's Claire Shen: the old EM playbook is structurally challenged — AI is displacing India's knowledge-economy jobs. IT firms once hiring tens of thousands now hire only hundreds of AI specialists. India at 50–60x earnings with these headwinds is a concern.
- Neuberger's YT Boon: Asia's Golden Triangle — Taiwan + Korea + Japan. The opportunity runs far beyond TSMC into mission-critical supply chain bottlenecks.

https://balfourcapitalgroup.com/news/

01/06/2026

🤖 DeepSeek is targeting a $50B valuation. OpenAI is at $850B. Anthropic is at $900B. The AI race is now a macro event.

The Bay (25 May 2026) examines the diverging US vs China AI strategies — and why the numbers reveal a global economy that is becoming dangerously dependent on AI capital expenditure to sustain growth.

The numbers that matter:

- $700B: US tech AI infrastructure spend forecast for 2026 — double 2025, which was double 2024
- 43%: share of US Q1 GDP growth attributable to AI capex (Jefferies — 1.15pp of 2.7% total growth)
- 50%: share of China's 14% April export growth attributable to overseas AI spending (Morgan Stanley)
- Hong Kong Q1 GDP +5.9%: driven partly by a 23.8% surge in exports — the regional AI windfall is broadening
- EBIT margins for AI-integrated companies: up 13 percentage points since 2021 to 17% — forward earnings projections lifted 60%

US vs China — two fundamentally different bets:

- US model: capital-intensive infrastructure dominance — OpenAI ($850B), Anthropic ($900B), massive data centre and semiconductor spend
- China model: cost-efficient, open-source deployment — DeepSeek ($50B), domestically integrated AI supply chain, lower capex exposure
- China's AI GDP risk: more contained — $85B AI spend adds just 0.2-0.3pp to annual real GDP, making a pullback more manageable

Balfour Capital's Hersh Oberoi:

- Cheaper AI broadens access — and broader access is what ultimately drives economic impact
- Morgan Stanley backs it: AI deployment could lift China's TFP by 3pp over the next decade, adding 3.5pp to potential GDP by 2035
- On valuations: unlike the dot-com era, today's AI leaders are generating real revenues and measurable enterprise adoption — not just momentum
- Key takeaway: AI capex is no longer just a tech story — it's a macro growth story. And when 43% of US economic expansion in one quarter runs through AI infrastructure spending, the risk of a capex cycle reversal is not a sector risk. It's a systemic one.

https://balfourcapitalgroup.com/news/

27/05/2026

Balfour Capital Group has issued the following buy recommendations:

Novanta Inc. (NASDAQ: NOVT) is a leading provider of precision motion, vision, and automation technologies used in minimally invasive surgery, robotics, medical diagnostics, semiconductors, and advanced industrial systems. The company supplies mission-critical solutions for OEMs across high-growth sectors including AI-driven automation and robotic surgery.

Takeda Pharmaceutical Company (NYSE: TAK) is a global biopharmaceutical leader focused on gastrointestinal disease, neuroscience, oncology, plasma-derived therapies, and vaccines. Key pipeline catalysts include oveporexton (TAK-861) for narcolepsy type 1 and zasocitinib for psoriasis, positioning the company for a major upcoming growth cycle.

Synopsys (NASDAQ: SNPS) is the world’s leading electronic design automation (EDA) company, providing essential chip design, semiconductor IP, and software integrity tools. Following its acquisition of Ansys, Synopsys now offers one of the industry’s most comprehensive simulation-to-silicon platforms serving the global semiconductor ecosystem.

View all buy recommendations: https://balfourcapitalgroup.com/buy-recommendations/

27/05/2026

🏦 Hong Kong's housing market is recovering. Its banks' property risk is not.

S&P Global Market Intelligence (21 May 2026) releases granular data on Hong Kong's five systemically important banks (D-SIBs) - and the numbers show that despite residential stabilisation, commercial real estate remains the real fault line.

The data - bank property exposures (end-2025):
Hang Seng Bank: highest retail property exposure (37.88%), highest CRE exposure (13.32%), Stage 3 impaired loans up 91 bps to 7.02%
HSBC: HK$3.682 trillion gross loans (2.1x second-ranked Bank of China HK); Stage 2 at 8.53%
ICBC (Asia): lowest retail exposure at 19.12% - but still rising from 17.83% a year prior
Standard Chartered HK and ICBC (Asia): the only two D-SIBs to post declines in both Stage 2 and Stage 3 loans

Balfour Capital's Hersh Oberoi - the risk call:
Residential stabilisation is supportive for sentiment - but does not materially reduce bank risk
The greater vulnerability: commercial real estate, where the picture is increasingly divergent
Early stress already emerging in smaller developers and non-prime assets
Impaired loan ratios likely to drift higher through 2026

Context from other sources:
IMF (May 15): banks well capitalised and liquid - but vigilance warranted in CRE and leveraged corporates
S&P Global Ratings' Will Hau: banking sector has sufficient buffers to absorb deeper collateral haircuts
Knight Frank: CRE bifurcation widening - prime CBD stable, non-core spaces under growing pressure

Key takeaway: System-level resilience is real. But CRE divergence and IFRS 9 Stage 2 migration are the risks to watch through 2026 - and the data is already moving in the wrong direction at Hang Seng.

https://balfourcapitalgroup.com/news/

20/05/2026

Japan's $1.5 trillion pension giant moved. The rest of the country's institutions are following.

AsianInvestor (19 May 2026) examines a profound structural shift: Japanese asset owners are moving private credit, private equity and infrastructure from peripheral side pockets to core allocation strategies — and the scale of capital involved makes this one of the most significant reallocation stories in global markets.

What is driving the pivot:
GPIF catalyst: the world's largest pension fund ($1.5T AUM) formally carved out alternatives in 2020 — when GPIF moves, smaller institutions follow
Demographics + yield scarcity: mounting payout obligations demand returns that JGBs simply cannot deliver
Regulatory tailwinds: capital efficiency requirements and Basel considerations making private credit attractive for life insurers and banks
Rising hedging costs: redirecting flows from currency-hedged foreign bonds toward unhedged global private markets
Semi-liquid and evergreen structures: easing operational concerns and building institutional comfort with private markets

Where the flows are going:
Private credit: strongest momentum — yield, regulatory efficiency, growing familiarity
Private equity: core for large institutions — focus on US and European markets
Infrastructure: energy transition projects in Southeast Asia and Australia — stable cash flows with ESG governance alignment

Balfour Capital's Hersh Oberoi:
Allocators are being pushed out of bonds and pulled toward alternatives simultaneously
Alternatives require a fundamentally different due diligence skillset — most Japanese institutions are still building specialist teams
Energy transition infrastructure offers stable cash flows with an ESG wrapper satisfying domestic governance requirements
The trajectory is clear — ex*****on speed is the constraint. Tokyo still has ground to make up.

Key takeaway: Japan's alternatives pivot is structural, not cyclical. Even gradual shifts from this base generate very significant global flows — and the reallocation has only just begun.

https://balfourcapitalgroup.com/news/

19/05/2026

Oil to $115-$120. No Fed cuts for six months. Gold floor at $4,000. These aren't predictions — they are live calls made on the NYSE floor on May 12, 2026.

At FEMACRO, Balfour Capital Group CIO Steve Alain Lawrence and team member Johan Boos delivered some of the most specific, time-stamped market calls we have recorded — in real time, on the day of the US CPI release and hours before the Xi Jinping-Trump summit.

Key calls from the interview:
Oil to $115-$120/bbl within 60-90 days — Straits of Hormuz disruption triggering a supply chain domino effect; June contract rolls May 19th.
Fed will NOT cut rates — possibly goes higher — inflation hot on services and energy; major bond players repositioning on the long end; Bank of America confirmed no 2026 cuts.
Gold floor: $4,000 — accumulate now — Middle East sovereign selling (NEOM, Saudi Olympics funding) is the cause of the pullback. Basing at $4,600-$4,700.
Pharma: Moderna (+18%), Pfizer, J&J, Eli Lilly — a sector left down for too long is now recovering. Significant value.
Chips/Semiconductors: buy the dip — Nvidia, Qualcomm, AMD named. 2-5% market pullback = absolute buying opportunity.

Every call is on record. We revisit them next episode.

Watch the full discussion: https://balfourcapitalgroup.com/media-coverage/

Balfour Capital Group

09/06/2026

08/06/2026

08/06/2026

04/06/2026

02/06/2026

01/06/2026

27/05/2026

27/05/2026

20/05/2026

19/05/2026

Address

Website

Alerts

Contact The Business

Shortcuts

Share

Category